Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Sell
17
IVF Quote, Financials, Valuation and Earnings
Last price:
$1.62
Seasonality move
:
3.99%
Day range:
$1.67 - $1.75
52-week range:
$1.38 - $17.04
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.15x
P/B ratio:
--
Volume:
63.7K
Avg. volume:
4.6M
1-year change:
-84.29%
Market cap:
$3.6M
Revenue:
$6.5M
EPS (TTM):
-$34.05
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, INVO Fertility has 255.03% upside to fair value with a price target of -- per share.
IVF vs. S&P 500
-
Over the past 5 trading days, INVO Fertility has underperformed the S&P 500 by -6.81% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
INVO Fertility does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
INVO Fertility has grown year-over-year revenues for 9 quarters straight. In the most recent quarter INVO Fertility reported revenues of $1.6M.
Earnings Growth
-
INVO Fertility has grown year-over-year earnings for 0 quarters straight. In the most recent quarter INVO Fertility reported earnings per share of -$12.53.
Enterprise value:
39.6M
EV / Invested capital:
4.04x
Price / LTM sales:
0.15x
EV / EBIT:
--
EV / Revenue:
6.01x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-6.18x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$2.7M
Return On Assets:
-94.64%
Net Income Margin (TTM):
-377.72%
Return On Equity:
-714.24%
Return On Invested Capital:
-313.33%
Operating Margin:
-150.4%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1M | $4.2M | $6.6M | $1.6M | $1.6M | |
| Gross Profit | $100.4K | $1.7M | $2.7M | $726.1K | $592.3K | |
| Operating Income | -$10.2M | -$5.4M | -$9.1M | -$946.4K | -$2.5M | |
| EBITDA | -$10.3M | -$5.8M | -$22.8M | -$1.2M | -$16.9M | |
| Diluted EPS | -$209.52 | -$62.27 | -$34.05 | -$7.55 | -$12.53 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $9.6M | $4.4M | $2.8M | $1.7M | $1.6M | |
| Total Assets | $10.2M | $8.5M | $6.2M | $18.3M | $31.7M | |
| Current Liabilities | $1.9M | $1.1M | $4.5M | $9M | $18.7M | |
| Total Liabilities | $4.6M | $2.9M | $6.1M | $18.3M | $28.4M | |
| Total Equity | $5.6M | $5.6M | $88.5K | $10.2K | $3.3M | |
| Total Debt | $343.1K | -- | $1.1M | $2.9M | $6.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$5.7M | -$3.9M | -$6.3M | -$260.6K | -$3.5M | |
| Cash From Investing | -$7.8K | -$2.5M | $373.4K | -$24.1K | -$14.7K | |
| Cash From Financing | $4M | $4.7M | $6.3M | $527.4K | $3.7M | |
| Free Cash Flow | -$5.7M | -$4.4M | -$6.4M | -$310.3K | -$3.6M | |
IVF
Sector
Market Cap
$3.6M
$33.4M
Price % of 52-Week High
9.92%
45.16%
Dividend Yield
0%
0%
Shareholder Yield
-646.83%
-0.66%
1-Year Price Total Return
-84.29%
-40%
Beta (5-Year)
2.227
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.80
200-day SMA
Sell
Level
$6.64
Bollinger Bands (100)
Sell
Level
1.49 - 5.65
Chaikin Money Flow
Sell
Level
-311.3M
20-day SMA
Sell
Level
$1.95
Relative Strength Index (RSI14)
Sell
Level
42.18
ADX Line
Buy
Level
20.79
Williams %R
Buy
Level
-86.1111
50-day SMA
Sell
Level
$2.01
MACD (12, 26)
Sell
Level
-0.12
25-day Aroon Oscillator
Buy
Level
4
On Balance Volume
Neutral
Level
740.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.2803)
Sell
CA Score
(Annual)
Level (-2.8374)
Buy
Beneish M-Score
(Annual)
Level (-2.2384)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (5.8615)
Buy
Piotroski F Score
(Annual)
Level (4)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic; The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell; and The Therapeutics segment consisting of financial information relating to acquired subsidiary, NTI.
Stock Forecast FAQ
In the current month, IVF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IVF average analyst price target in the past 3 months is --.
-
Where Will INVO Fertility Stock Be In 1 Year?
According to analysts, the consensus estimate is that INVO Fertility share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About INVO Fertility?
Analysts are divided on their view about INVO Fertility share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that INVO Fertility is a Sell and believe this share price will drop from its current level to --.
-
What Is INVO Fertility's Price Target?
The price target for INVO Fertility over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IVF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for INVO Fertility is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of IVF?
You can purchase shares of INVO Fertility via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase INVO Fertility shares.
-
What Is The INVO Fertility Share Price Today?
INVO Fertility was last trading at $1.62 per share. This represents the most recent stock quote for INVO Fertility. Yesterday, INVO Fertility closed at $1.69 per share.
-
How To Buy INVO Fertility Stock Online?
In order to purchase INVO Fertility stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for Jun 2
Regeneron Pharmaceuticals [REGN] is up 1.82% over the past day.
Buy
55
RGC alert for Jun 2
Regencell Bioscience Holdings [RGC] is down 13.34% over the past day.
Sell
42
AMBA alert for Jun 2
Ambarella [AMBA] is down 0.91% over the past day.
